Patient‐centered and proportionate safety reporting in clinical trials facilitates evidence‐based medicine for the benefit of patients and society: An EHA priority

Documenti analoghi

• Fair Pricing of Innovative Medicines: An EHA Position Paper
  di: Anton Hagenbeek, et al.
  Pubblicazione: (2020-10-01)
• Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
  di: Giampaolo Merlini, et al.
  Pubblicazione: (2020-10-01)
• Patient‐centered and proportionate safety reporting in clinical trials facilitates evidence‐based medicine for the benefit of patients and society: An EHA priority
  di: Tarec Christoffer El‐Galaly, et al.
  Pubblicazione: (2025-10-01)
• The EHA Research Roadmap: Transfusion Medicine
  di: Simon J. Stanworth, et al.
  Pubblicazione: (2022-02-01)
• EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
  di: Sabine Blum, et al.
  Pubblicazione: (2021-09-01)